scholarly journals Improvement in the quality of life in women with stress urinary incontinence after surgery for pelvic organ prolapse

2019 ◽  
Vol 72 (7-8) ◽  
pp. 197-201
Author(s):  
Ljiljana Mladenovic-Segedi
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Surgical Treatment ◽  
Pelvic Organ Prolapse ◽  
Stress Urinary Incontinence ◽  
Urge Urinary Incontinence ◽  
Pelvic Organ ◽  
Posterior Colporrhaphy ◽  
Average Value

Introduction. Pelvic organ prolapse is commonly associated with symptomatic stress urinary incontinence, in up to 50% of patients. The aim of our research was to examine the quality of life of women with urinary incontinence and pelvic organ prolapse after conventional surgical treatment. Material and Methods. The research included 50 patients with stress urinary incontinence and pelvic organ prolapse that underwent vaginal hysterectomy with anterior and posterior colporrhaphy. The pelvic organ prolapse-quantification system was used to determine the degree of genital prolapse. All patients completed a questionnaire to determine the ?stress and urge? score preoperatively, as well as the Urinary Distress Inventory-6 and Urinary Impact Questionnaire-7 during the follow-up examination, a year after the surgery. Results. One year after surgery, 20 patients (40%) presented with a recurrence of cystocele. The average value of the Urinary Distress Inventory-6 questionnaire a year after surgery was 29.0 ? 10.8, while the average value of the Urinary Impact Questionnaire-7 questionnaire was 3.7 ? 16.3. After the surgery, 6 patients (12%) had persistent stress urinary incontinence and 4 patients (8%) had urge urinary incontinence. Among patients with persistent stress urinary incontinence, two patients reported pronounced symptoms of stress urinary incontinence and reoperation was performed. Conclusion. The classical surgical treatment of pelvic organ prolapse with anterior and posterior colporrhaphy leads to improvement in the quality of life of patients with pelvic organ prolapse and stress urinary incontinence. If the symptoms of stress urinary incontinence persist after classical surgical treatment, other anti-incontinence surgical modalities should be considered.

scholarly journals Clinical Outcomes and Urodynamic Effects of Tailored Transvaginal Mesh Surgery for Pelvic Organ Prolapse

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Ting-Chen Chang ◽  
Sheng-Mou Hsiao ◽  
Chi-Hau Chen ◽  
Wen-Yih Wu ◽  
Ho-Hsiung Lin
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Pelvic Organ Prolapse ◽  
Stress Urinary Incontinence ◽  
Clinical Outcomes ◽  
Positive Impact ◽  
Pelvic Organ ◽  
Transvaginal Mesh ◽  
Mesh Surgery

Objective. To evaluate the clinical outcomes and urodynamic effects of tailored anterior transvaginal mesh surgery (ATVM) and tailored posterior transvaginal mesh surgery (PTVM).Methods. We developed ATVM for the simultaneous correction of cystocele and stress urinary incontinence and PTVM for the simultaneous correction of enterocoele, uterine prolapse, vaginal stump prolapse, and rectocele.Results. A total of 104 women enrolled. The median postsurgical follow-up was 25.5 months. The anatomic cure rate was 98.1% (102/104). Fifty-eight patients underwent urodynamic studies before and after surgeries. The pad weight decreased from 29.3 ± 43.1 to 6.4 ± 20.9 g at 3 months. Among the 20 patients with ATVM, 13 patients had objective stress urinary incontinence (SUI) at baseline while 8 patients came to have no demonstrated SUI (NDSUI), and 2 improved after surgery. Among the 38 patients who underwent ATVM and PTVM, 24 had objective SUI at baseline while 18 came to have NDSUI, and 2 improved after surgery. Mesh extrusion (n= 4), vaginal hematoma (n= 3), and voiding difficulty (n= 2) were noted postoperatively. Quality of life was substantially improved.Conclusions. Our findings document the advantages of these two novel pelvic reconstructive surgeries for pelvic organ prolapse, which had a positive impact on quality of life. ATVM surgery additionally provided an anti-incontinence effect. This clinical trial is registered at ClinicalTrials.gov (NCT02178735).

Use of a simple in vitro fatigue test to assess materials used in the surgical treatment of stress urinary incontinence and pelvic organ prolapse

2018 ◽  
Vol 38 (1) ◽  
pp. 107-115 ◽  
Author(s):  
Sabiniano Roman ◽  
Naside Mangir ◽  
Lucie Hympanova ◽  
Christopher R. Chapple ◽  
Jan Deprest ◽  
...  
Keyword(s):  
Urinary Incontinence ◽  
Surgical Treatment ◽  
Pelvic Organ Prolapse ◽  
Stress Urinary Incontinence ◽  
Fatigue Test ◽  
Pelvic Organ ◽  
Materials Used

scholarly journals Knowledge, Attitude and Practice of Physician toward Pelvic Floor Dysfunction KAP of Physician toward PFD

2019 ◽  
Vol 3 (1) ◽  
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Pelvic Organ Prolapse ◽  
Fecal Incontinence ◽  
Pelvic Floor ◽  
Pelvic Floor Dysfunction ◽  
Pelvic Organ ◽  
Attitude And Practice ◽  
Knowledge Attitude And Practice

Pelvic floor dysfunction (PFD) as a term includes underlying different sub-conditions the major ones are pelvic organ prolapse (POP), urinary incontinence (UI), fecal incontinence (FI), sexual function. The direct effect of dysfunction in these areas can affect the quality of life on a personal and healthy level in patients with PFD.

scholarly journals Quality of life and sexual function after TVT surgery versus Bulkamid injection for primary stress urinary incontinence: 1 year results from a randomized clinical trial

2020 ◽  
Author(s):  
Anna-Maija Itkonen Freitas ◽  
Tomi S. Mikkola ◽  
Päivi Rahkola-Soisalo ◽  
Sari Tulokas ◽  
Maarit Mentula
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Stress Urinary Incontinence ◽  
Sexual Function ◽  
Short Form ◽  
Pelvic Organ ◽  
Health Related Qol ◽  
Long Term Follow Up ◽  
Health Related

Abstract Introduction and hypothesis To assess changes in quality of life (QoL) and sexual function outcomes at 1 year after tension-free vaginal tape (TVT) versus polyacrylamide hydrogel injection (PAHG). Methods In a randomized trial comparing TVT (n = 111) and PAHG (n = 113) treatments of stress urinary incontinence (SUI), we compared urinary incontinence and health-related QoL using the Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire, Short Form (IIQ-7), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and RAND-36 Item Health Survey (RAND-36) at baseline and 1 year. Results UDI-6 and IIQ-7 showed improved incontinence-related QoL (p = 0.001) from baseline in both groups except for difficulty emptying the bladder and pain/discomfort. At 1 year, TVT patients experienced less urinary symptom-related distress compared to PAHG (p < 0.001). Sexual function improved in both groups (p < 0.001 for TVT and p = 0.01 for PAHG) with higher scores for the physical section subscale (p < 0.001) for TVT. Health-related QoL (RAND-36) improved from baseline in both groups in physical and social functioning (p < 0.001) with better outcome in the TVT group for physical functioning (p < 0.001). Increase in pain from baseline (p = 0.02) was detected for TVT, but not for PAHG. However, there was no difference between the groups (p = 0.78). Conclusions In primary SUI, TVT and PAHG treatments both improved QoL and sexual function at 1 year. However, incontinence and health-related QoL scores were better in the TVT group. More pain compared to the baseline was reported after TVT, although there was no difference between groups. Clinical significance needs to be evaluated in long-term follow-up.

Sign in / Sign up

Export Citation Format

Share Document